New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 8, 2022 - Indoco Remedies and Sagent Pharmaceuticals launched AP-rated generic versions of UCB’s Vimpat (lacosamide) injection.
Download PDF
Return to publications
